• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Isis Pharmaceuticals Inc

+ Add to Watchlist

ISIS:US

40.5300 USD 0.6300 1.58%

As of 12:41:13 ET on 08/29/2014.

Company Profile for Isis Pharmaceuticals Inc (ISIS)

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

Contact Information

Isis Pharmaceuticals Inc

1896 Rutherford Road
Carlsbad, CA 92008-7326
United States
Phone: 1-760-931-9200
Fax: 1-760-603-2700

Key Executives for Isis Pharmaceuticals Inc (ISIS)

Stanley T Crooke "Stan"Chairman/President/CEO/FounderB Lynne ParshallCOO/Secretary
Elizabeth L HougenSenior VP:Finance/CFOPatrick R O'NeilSenior VP:Legal/Gen Counsel
C Frank BennettSenior VP:Antisense ResearchRichard S GearySenior VP:Development
Brett P MoniaSenior VP:Drug DiscoveryD Wade WalkeVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil